NDC 70771-1625
Mesalamine 0.375 g capsule, extended release
On the label: Cadila Healthcare Limited.
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Zydus Lifesciences Limited | Ahmedabad, India | Makes it and tests it | Problems found, fixed voluntarilyMar 24, 2023 · 5 inspections |
Product details
- Generic drug
- Mesalamine: every company that makes it
- Form
- capsule, extended release, oral
- Strength
- 0.375 g
- Approval
- ANDA ANDA208954
- On the market since
- Aug 13, 2021
- Package NDCs
70771-1625-7- Official label
- DailyMed (National Library of Medicine), updated Nov 30, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?